Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.
Crit Care. 2017 Jun 22;21(1):157. doi: 10.1186/s13054-017-1744-8.
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) support under extracorporeal cardiopulmonary resuscitation (eCPR) is the last option and may be offered to selected patients. Several factors predict outcome in these patients, including initial heart rhythm, comorbidities, and bystander cardiopulmonary resuscitation (CPR). We evaluated outcomes of all VA-ECMO patients treated within the last 5 years at our center in respect to low-flow duration during CPR.
We report retrospective registry data on all patients with eCPR treated at a university hospital between October 2010 and May 2016.
A total of 133 patients (mean age 58.7 ± 2.6 years, Simplified Acute Physiology Score II score at admission 48.1 ± 3.4) were included in the analysis. The indication for eCPR was either in-hospital or out-of-hospital cardiac arrest without return of spontaneous circulation (n = 74 and 59, respectively). There was a significant difference in survival rates between groups (eCPR in-hospital cardiac arrest [IHCA] 18.9%, eCPR out-of-hospital cardiac arrest [OHCA] 8.5%; p < 0.042). Mean low-flow duration (i.e., duration of mechanical CPR until VA-ECMO support) was 59.6 ± 5.0 minutes in all patients and significantly shorter in IHCA patients than in OHCA patients (49.6 ± 5.9 vs. 72.2 ± 7.4 minutes, p = 0.001). Low-flow time strongly correlated with survival (p < 0.001) and was an independent predictor of mortality.
Time to full support is an important and alterable predictor of patient survival in eCPR, suggesting that VA-ECMO therapy should be established as fast as possible in the selected patients destined for eCPR.
体外心肺复苏(eCPR)下的动静脉体外膜肺氧合(VA-ECMO)支持是最后的选择,可能会提供给选定的患者。在这些患者中,有几个因素可以预测预后,包括初始心律、合并症和旁观者心肺复苏(CPR)。我们评估了我们中心在过去 5 年内治疗的所有 VA-ECMO 患者的结局,以了解 CPR 期间低流量持续时间的情况。
我们报告了 2010 年 10 月至 2016 年 5 月在一家大学医院接受 eCPR 治疗的所有患者的回顾性登记数据。
共纳入 133 例患者(平均年龄 58.7±2.6 岁,入院时简化急性生理学评分 II 评分 48.1±3.4)。eCPR 的适应证分别为院内或院外心脏骤停且无自主循环恢复(分别为 74 例和 59 例)。两组的生存率有显著差异(院内心脏骤停 eCPR [IHCA] 18.9%,院外心脏骤停 eCPR [OHCA] 8.5%;p<0.042)。所有患者的平均低流量持续时间(即机械 CPR 至 VA-ECMO 支持的时间)为 59.6±5.0 分钟,IHCA 患者明显短于 OHCA 患者(49.6±5.9 与 72.2±7.4 分钟,p=0.001)。低流量时间与生存率强烈相关(p<0.001),是死亡率的独立预测因素。
达到全面支持的时间是 eCPR 患者生存的一个重要且可改变的预测因素,这表明在选定的 eCPR 患者中,VA-ECMO 治疗应尽快建立。